v3.25.2
Consolidated Condensed Statements of Cash Flows (Unaudited) - USD ($)
$ in Thousands
 6 Months Ended
Jun. 30, 2025
Jun. 30, 2024
Operating activities:    
Net loss $ (47,924) $ (53,405)
Adjustments to reconcile net loss to net cash used in operating activities:    
Share-based compensation 3,691 4,946
Stock issued for services 50 0
Depreciation 4,708 3,847
Debt related fees and amortization expense 3,770 3,241
Intangibles and other amortization expense 23 24
Accretion and other expenses of Series A preferred units 4,311 6,788
Loss on asset disposals 0 3,644
Changes in operating assets and liabilities:    
Accounts receivable (444) (145)
Inventories 12,958 8,028
Prepaid expenses 274 1,082
Tax credit sale receivable 12,300 0
Other assets 150 (1,318)
Accounts payable (9,467) (5,961)
Accrued interest expense and fees 9,380 12,614
Other liabilities 643 1,243
Net cash used in operating activities (5,577) (15,372)
Investing activities:    
Capital expenditures (5,350) (8,980)
Grant proceeds and other reimbursements received for capital expenditures 411 3,045
Net cash used in investing activities (4,939) (5,935)
Financing activities:    
Proceeds from borrowings 21,319 8,436
Repayments of borrowings (25,411) (4,015)
Payments on Series A preferred financing (2,200) 0
Lender debt renewal and waiver fee payments (495) (1,444)
Payments on finance leases (162) (161)
Proceeds from sales of common stock 17,960 15,891
Proceeds from exercise of stock options 257 36
Net cash provided by financing activities 11,268 18,743
Effect of exchange rate changes on cash, cash equivalents, and restricted cash 7 26
Net change in cash, cash equivalents, and restricted cash for period 759 (2,538)
Cash, cash equivalents, and restricted cash at beginning of period 3,831 6,280
Cash, cash equivalents and restricted cash at end of period 4,590 3,742
Supplemental disclosures of cash flow information, cash paid:    
Cash paid for interest 11,404 5,074
Income taxes paid 0 878
Supplemental disclosures of cash flow information, non-cash transactions:    
Settlement of AP via issuance of Common Stock 45 0
Subordinated debt extension fees added to debt 680 340
Fair value of warrants issued to subordinated debt holders 584 593
Lender debt extension, waiver, and other fees added to debt 2,595 595
Cumulative capital expenditures in accounts payable $ 14,429 $ 11,360